BioCentury
ARTICLE | Clinical News

Seroquel XR quetiapine fumarate regulatory update

May 12, 2008 7:00 AM UTC

AstraZeneca submitted an sNDA to FDA for Seroquel XR quetiapine to treat generalized anxiety disorder (GAD). The sustained-release formulation of the dibenzothiazepine atypical antipsychotic is approv...